NSEAnalysts/Institutional Investor Meet/Con. Call Updates4d ago · 6 Nov 2026, 04:27 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Natco Pharma Limited · NATCOPHARM
✦ AI SummaryResults
Natco Pharma Limited will host an earnings call with investors/analysts on November 13, 2026, to discuss its un-audited financial results for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
NATCOPHARM_06112026162736_ConcallIntimationtoSE06112026.pdf
View document text
6th November, 2026
Corporate Relationship Department The Manager - Listing
M/s. BSE Limited M/s. National Stock Exchange of India Ltd
Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex
Mumbai 400001 Bandra (E) Mumbai 400051
Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir/Madam,
Sub:- Q2FY27 Un audited Financial Results Earnings Call
The Company will host an Earnings Call with Investors / Analysts on Friday, the 13th November,
2026 at 16:00 PM IST to discuss the Un-audited Financial Results of the Company for the
quarter ended 30th September, 2026.
Copy of the same is enclosed for your ready reference.
This is for your information and records.
Thanking you,
Yours faithfully,
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer
Encl.: As above
Earnings Call
Q2FY27
Join us for a discussion on our quarterly performance.
DATE & TIME
November 13, 2026 (Friday) | 16:00 Hrs IST
Pre-register by CLICKING HERE TO REGISTER FOR THE ZOOM CALL
Please join 5 minutes prior to the call.
NATCO PHARMA LIMITED | Q2FY27